Code is covered without prior authorization (high confidence)
Medicare Pricing
Work RVU
0.00
Facility
N/A
Non-Facility
N/A
Key Coverage Criteria
The use of DMEK, DSEK, DSAEK and DMAEK, is consideredmedically necessaryfor the treatment of disorders of the corneal endothelium, including but not limited to the following:
Fuchs’ endothelial dystrophy;
Aphakic and pseudophakic bullous keratopathy (corneal edema following cataract extraction);
Failure or rejection of a previous corneal transplant.